Upgrade to SI Premium - Free Trial

Organogenesis Holding (ORGO)

2.43 -0.04 (1.62%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 July 9, 2026 7:30 AM - StreetInsider FDA accepts Organogenesis BLA for knee osteoarthritis treatment ReNu July 6, 2026 4:05 PM - StreetInsider Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis July 6, 2026 4:05 PM - StreetInsider Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself June 18, 2026 12:43 PM - StreetInsider Form 8-K Organogenesis Holdings For: Jun 15 June 16, 2026 4:33 PM - SEC Filing The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It June 16, 2026 10:30 AM - StreetInsider Truist Securities Starts Oranogenesis Holdings (ORGO) at Hold May 28, 2026 6:06 AM - StreetInsider BTIG Downgrades Oranogenesis Holdings (ORGO) to Neutral May 8, 2026 5:33 AM - StreetInsider Organogenesis Holding (ORGO) Misses Q1 EPS by 15c May 7, 2026 5:46 PM - StreetInsider Form 10-Q Organogenesis Holdings For: Mar 31 May 7, 2026 4:20 PM - SEC Filing Form 8-K Organogenesis Holdings For: May 07 May 7, 2026 4:14 PM - SEC Filing Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results May 7, 2026 4:05 PM - StreetInsider Form ARS Organogenesis Holdings For: Dec 31 April 30, 2026 4:26 PM - SEC Filing Form DEF 14A Organogenesis Holdings For: Jun 15 April 30, 2026 4:22 PM - SEC Filing Organogenesis completes FDA submission for knee arthritis treatment April 28, 2026 4:30 PM - StreetInsider Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® April 28, 2026 4:30 PM - StreetInsider Form 4 Organogenesis Holdings For: Jan 10 Filed by: Grow Brian April 24, 2026 9:30 PM - SEC Filing Full Article List